Go offline with the Player FM app!
Podcasts Worth a Listen
SPONSORED


1 America’s Sweethearts: Dallas Cowboys Cheerleaders Season 2 - Tryouts, Tears, & Texas 32:48
Civilization Ventures: Lessons learned from founding, exiting and applying them to support founders as an investor
Manage episode 411441733 series 3284224
Shahram Seyedin-Noor is the founder and managing partner at Civilization Ventures. Shahram received a JD from Harvard and worked at Wilson Solsinis and Cooley before going into investment banking at firms like Goldman Sachs and Bank of America. He then entered the startup world co-founding several startups. He eventually ended up Angel investing and in 2017, launched Civilization Ventures, focused on supporting cutting-edge innovations in health tech and biology. Shahram has over a dozen exits under his belt, which is a phenomenal achievement. Here are some of his investments: Rewrite (acq. by Intellia), Replace (acq. by Tome), Lemonaid (acq. by 23andme), Singular Bio (acq. by Invitae), Rocket Pharma (listed on Nasdaq), Palamedrix (acq. by SomaLogic), Foresight Diagnostics, BillionToOne, Omada and others. Shahram takes an active role in company building. Prior to founding CV, Shahram was the founding CEO/Chairman of Inspirna, an oncology therapeutics company currently in Phase 2 human trials, and the CFO and VP of Corporate Development at NextBio, a genomics software pioneer acquired by Illumina. Shownotes:
- https://www.civilizationventures.com/
- Success has a thousand fathers but failure is an orphan
- Accountability: Few people blame themselves for failure and give credit for success to others
- Evolution of mindset: Don’t let others dictate what you can or supposed to do in life
- EQ is more/equally important than IQ
- Transition from law school to startups
- Advice for recruiting a non-scientific co-founder
- Rewrite therapeutics acquired by Intellia
- Investment thesis at Civilization Ventures: Drive to do things differently
- Lessons learned from exits
- Contact email: shahram@civilizationventures.com
61 episodes
Manage episode 411441733 series 3284224
Shahram Seyedin-Noor is the founder and managing partner at Civilization Ventures. Shahram received a JD from Harvard and worked at Wilson Solsinis and Cooley before going into investment banking at firms like Goldman Sachs and Bank of America. He then entered the startup world co-founding several startups. He eventually ended up Angel investing and in 2017, launched Civilization Ventures, focused on supporting cutting-edge innovations in health tech and biology. Shahram has over a dozen exits under his belt, which is a phenomenal achievement. Here are some of his investments: Rewrite (acq. by Intellia), Replace (acq. by Tome), Lemonaid (acq. by 23andme), Singular Bio (acq. by Invitae), Rocket Pharma (listed on Nasdaq), Palamedrix (acq. by SomaLogic), Foresight Diagnostics, BillionToOne, Omada and others. Shahram takes an active role in company building. Prior to founding CV, Shahram was the founding CEO/Chairman of Inspirna, an oncology therapeutics company currently in Phase 2 human trials, and the CFO and VP of Corporate Development at NextBio, a genomics software pioneer acquired by Illumina. Shownotes:
- https://www.civilizationventures.com/
- Success has a thousand fathers but failure is an orphan
- Accountability: Few people blame themselves for failure and give credit for success to others
- Evolution of mindset: Don’t let others dictate what you can or supposed to do in life
- EQ is more/equally important than IQ
- Transition from law school to startups
- Advice for recruiting a non-scientific co-founder
- Rewrite therapeutics acquired by Intellia
- Investment thesis at Civilization Ventures: Drive to do things differently
- Lessons learned from exits
- Contact email: shahram@civilizationventures.com
61 episodes
All episodes
×
1 Solving the CRISPR delivery problem using a proprietary peptide-based platform 1:05:53

1 Altitude Lab Fund- Supporting healthcare founders in challenging times 51:41

1 Partnering to accelerate therapeutics: A primer on forming alliances and their management 50:40

1 From Pitches to Stories: Transforming Complex Ideas into Engaging Narratives 54:11

1 Turning great science into impactful medicine: Lessons from Corey Goodman, Pioneer in Science and Venture Capital 1:21:13

1 Pushing Boundaries: Abhishek Tripathi’s Experience with NASA, SpaceX, UC Berkeley and Startups 1:01:24

1 Lessons from Evolution of Innovation and Entrepreneurship Ecosystem at UC Berkeley 58:06

1 Civilization Ventures: Lessons learned from founding, exiting and applying them to support founders as an investor 54:45

1 Humba Ventures: Investing in Deep Tech Startups with Engineering Focus 53:11

1 Berkeley Skydeck- Catalyzing the growth of deep tech startups at the world’s number one ranked public university. 52:08

1 Medtech Innovator and Biotools Innovator: accelerator for medical device, digital health and diagnostic companies 1:12:25

1 Metcela - Treating chronic organ diseases using a novel fibroblast-based technology 58:06

1 Lessons learned from a scientist entrepreneur turned investor 1:16:45

1 NAMUH - Attempt at closing the gap between infant formula and human breast milk 1:05:44

1 NASA fueling innovation through SBIR/STTR, Awards & Prizes 48:32


1 Feeding our astronauts - Reflections of a NASA food scientist 1:08:25

1 Developing foundational tools for engineering metabolism inside cells to solve important societal problems. 57:28

1 PCDworks: Hardtech Basecamp Incubator for building hardware products 1:00:15

1 VeriSIM Life: Using AI to build translational indices to push better drug moieties into clinicals 1:09:22

1 Osage University Partners- Funding university spinouts 55:43

1 Legal 101 for deeptech founders; Understanding the basics; dilution, and safeguarding employee equity 1:18:13

1 Cuberg- Next generation Lithium metal battery technology for the electric mobility industry 1:13:10

1 Gradient- Building smart heat pumps that use better coolants to cool and heat the world 58:35

1 Valitor- Engineering better medicines by leveraging its multi-valent biopolymer technology 57:51

1 Translating lessons learnt on diversity from academia to startups and the tech world. 59:31

1 [REPLAY] Building the startup muscle for academic founders. 50:16

1 Nucleate Bio- A collaborative student-led organization that facilitates the formation of pioneering life sciences companies 1:06:35

1 Activate- Empowering scientists to bring their research to market 1:04:27

1 National Security Innovation Capital (NSIC)- Funding dual-use hardware startups 37:22

1 Market intelligence reports for startups - Arkady Hagopian 48:44

1 Revolutionizing organ preservation and transplantation by mimicking antifreeze proteins of Arctic fish 1:17:22

1 Building the Bay Area Life Sciences Startup Ecosystem 1:13:48

1 RH Capital (a Rhia Venture Fund): Investing in reproductive and maternal health 52:36

1 Caribou Biosciences- Developing CRISPR based genome-edited, off-the-shelf immune cell therapies for the treatment of cancer. 1:09:40

1 Nodexus- Benchtop single cell sorting and dispensing 55:54

1 Raydiant Oximetry- Preventing unnecessary C-Sections and making childbirth safer 52:37

1 Ignite Immunotherapy- Success story of novel “build to buy” business model with Pfizer 48:58

1 UbiQD- Leveraging quantum dots to improve crop yield & harvesting sunlight to generate electricity 1:03:33

1 Calwave Energy- Unlocking the power of ocean by harvesting energy from waves 59:59

1 Horizon Partners- M&A for bootstrapped technology companies 49:21

1 University of Tokyo Edge Capital Partners- Investing and supporting startups from the seed/early stages in academia in Japan and abroad. 46:40

1 Ayar Labs: Disrupting semiconductor and computing industries while dramatically reducing energy usage 1:01:22

1 Bakar Bioenginuity Hub- Accelerating research to realization 1:11:44
Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.